{"database": "lobbying", "table": "lobbying_activities", "rows": [[2183580, "a50e49f9-f4ea-4ffb-8bde-992f38e44082", "Q3", "CARDINAL POINT PARTNERS", 308992, "TONIX PHARMACEUTICALS, INC.", 2018, "third_quarter", "VET", "Department of Veterans Affairs research and development on neuropsychiatric drug treatments", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2018-10-12T16:25:16.403000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2183580"], "units": {}, "query_ms": 0.3226259723305702, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}